Elevance Health Inc. (ELV) Misses Q3 EPS by $1.29, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Elevance (ELV) PT Lowered to $515 at Leerink Partners
October 21, 2024 5:57 AM EDTLeerink Partners analyst Whit Mayo lowered the price target on Elevance (NYSE: ELV) to $515.00 (from $620.00) while maintaining a Outperform rating.
The analyst comments "Bottom Line: Reiterate Outperform Rating. 3Q results brought forth a material acceleration of pressures within Medicaid as a result of... More
Elevance (ELV) PT Lowered to $478 at RBC Capital
October 18, 2024 7:04 AM EDTRBC Capital analyst Ben Hendrix lowered the price target on Elevance (NYSE: ELV) to $478.00 (from $585.00) while maintaining a Outperform rating.
The analyst comments "ELV shares traded off today as management lowered its 2024 EPS guidance and guided to mid-single-digit EPS growth in 2025, down from... More
